Latest News about FDA
Recent news which mentions FDA
From Benzinga
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
May 22, 2024
From Benzinga
Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%
May 22, 2024
From Benzinga
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
May 21, 2024
From Benzinga
From Benzinga
Biden's Greenlight: What To Know About Fed-Regulated Marijuana, Markets, Legal Circuits And Compliance
May 16, 2024
From Benzinga
From Benzinga
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
May 15, 2024
From Benzinga
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
May 14, 2024
From Benzinga
From Benzinga
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
May 10, 2024
From Benzinga
From Benzinga
Why Outset Medical Shares Are Up Today
May 06, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free